SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-141426
Filing Date
2019-05-08
Accepted
2019-05-08 16:16:02
Documents
3
Period of Report
2019-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d745291d8k.htm 8-K 20895
2 EX-99.1 d745291dex991.htm EX-99.1 88085
3 GRAPHIC g745291g0508060404289.jpg GRAPHIC 3125
  Complete submission text file 0001193125-19-141426.txt   114577
Mailing Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF RD 9TH FLOOR BOSTON MA 02210 617-207-0202
AKCEA THERAPEUTICS, INC. (Filer) CIK: 0001662524 (see all company filings)

IRS No.: 472608175 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38137 | Film No.: 19806794
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1